Medical Imaging (MEDD) 10-Q 14 Aug 15 2015 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 14, 2015
Document And Entity Information
Entity Registrant Name	MEDICAL IMAGING CORP.
Entity Central Index Key	1,370,804
Document Type	10-Q
Document Period End Date	Jun. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		24,166,481
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,015

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current Assets
Cash and Cash Equivalents	$ 34,738	$ 188,206
Accounts Receivable, net	1,310,502	851,884
Prepaid Expenses	41,244	24,165
Total Current Assets	1,386,484	1,064,255
Property and Equipment
Equipment	3,461,215	3,402,671
Less: Accumulated Depreciation	(732,133)	(463,977)
Total Property and Equipment, net	2,729,082	2,938,694
Goodwill	1,977,670	1,977,670
Other Assets
Deposits	12,161	12,463
Loan Receivable	0	1,497
Total Other Assets	12,161	13,960
TOTAL ASSETS	6,105,397	5,994,579
Current Liabilities
Accounts Payable	764,660	624,141
Accrued Taxes Payable	327,544	311,547
Obligations Under Capital Lease, short term portion	208,519	189,923
Promissory Notes, short term portion	381,269	134,999
Royalty Financing, short term portion	103,467	102,219
Convertible Notes, net short term portion	2,035,127	54,263
Total Current Liabilities	3,820,586	1,417,092
Long Term Liabilities
Obligations Under Capital Lease, long term portion	378,916	459,853
Royalty Financing, long term portion	1,884,156	1,902,698
Convertible Notes, net, long term portion	388,262	2,332,708
Total Long Term Liabilities	2,651,334	4,695,259
Total Liabilities	6,471,920	6,112,351
Stockholders' Deficit
Preferred Stock	0	0
Common Stock	24,167	23,947
Additional Paid-In Capital	1,970,223	1,876,484
Accumulated Other Comprehensive Gain	78,444	21,393
Accumulated Deficit	(2,439,357)	(2,039,596)
Total Stockholders' Deficit	(366,523)	(117,772)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 6,105,397	$ 5,994,579

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value in dollars	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value in dollars	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	24,166,481	23,946,481
Common stock, shares outstanding	24,166,481	23,946,481

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue:
Sales	$ 2,004,301	$ 1,316,125	$ 3,824,818	$ 2,512,062
Less: Cost of Sales	976,238	796,126	1,927,704	1,501,621
Gross Margin	1,028,063	519,999	1,897,114	1,010,441
Operating Expenses:
Advertising	8,066	17,730	17,582	34,253
Amortization	0	0	0	22,925
Depreciation	137,014	39,835	272,738	79,655
Bad Debt Expense (Recapture)	6,379	7,458	6,379	14,980
General and Administrative	163,623	53,974	352,425	108,497
Insurance	24,212	11,362	49,162	23,108
Labor	307,722	185,784	639,493	376,264
Legal and Professional	79,300	56,852	222,195	98,078
Management Fees	5,100	4,666	23,413	9,088
Rent Office Space and Servers	132,759	34,586	265,452	73,722
Travel	12,596	12,082	21,111	26,470
Total Operating Expenses	876,771	424,329	1,869,950	867,040
Income from Operations	151,292	95,670	27,164	143,401
Other Income and (Expenses):
Other Income	2,621	43	8,645	203
Foreign Currency Gains (Losses)	(19,755)	394	(17,519)	809
Amortization of Debt Discount	(177,607)	(22,640)	(289,898)	(42,996)
Interest Expense	(15,397)	(82,467)	(173,209)	(150,692)
Total Other Income (Expenses)	(210,138)	(104,670)	(471,981)	(192,676)
Loss Before Provision for Income (Taxes) Credit	(58,846)	(9,000)	(444,817)	(49,275)
Provision for Income (Taxes) Credit	45,056	0	45,056	0
Net Income (Loss)	(13,790)	(9,000)	(399,761)	(49,275)
Comprehensive Income (Loss)	37,654	(1,336)	57,051	(271)
Total Comprehensive Income (Loss)	$ 23,864	$ (10,336)	$ (342,710)	$ (49,546)
Basic and Diluted Loss per Share	$ 0.001	$ 0	$ (0.014)	$ (0.002)
Weighted Average Shares Outstanding - Basic and Diluted	24,166,481	23,767,195	24,131,342	23,605,790

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ (399,761)	$ (49,275)
Adjustments to Reconcile Net Loss to Net Cash provided by Operating Activities:
Depreciation	272,738	79,655
Asset Write Off	0	1,009
Accrued Interest Converted into note	0	132,707
Amortization of Debt Discount	289,898	42,996
Stock-based compensation	92,919	150
Amortization of Intangible Assets	0	22,925
Foreign currency transaction (Gain) Loss	429	64
Changes in operating assets and liabilities:
Accounts Receivable	(458,618)	(89,648)
Deposits and prepaid expenses	(17,079)	(5,269)
Accounts Payable and accrued liabilities	156,516	12,291
Loans Receivable	1,497	616
NET CASH AND CASH EQUIVALENTS PROVIDED BY OPERATING ACTIVITIES	(61,461)	148,221
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments on acquisition liability	0	(110,062)
Deposit on possible acquisition	0	(20,000)
Deposit on equipment	0	(100,650)
Equipment Purchase	(42,806)	(87,401)
NET CASH USED IN INVESTING ACTIVITIES	(42,806)	(318,113)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from debt issuance	874,044	445,000
Principal payments on debt	(897,526)	(160,758)
Principal Payments on Capital Lease Obligations	(82,770)	(41,291)
NET CASH AND CASH EQUIVALENTS USED BY IN FINANCING ACTIVITIES	(106,252)	242,951
Gain (Loss) due to foreign currency translation	57,051	(271)
NET CHANGE IN CASH AND CASH EQUIVALENTS	(153,468)	72,788
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	188,206	77,300
CASH AND CASH EQUIVALENTS AT END OF PERIOD	34,738	150,088
Cash paid during the year for:
Interest	173,209	17,985
Income Taxes	28,813	36,555
Non-cash financing and investing activities:
Shares Issued for Convertible Note	1,040	31,200
Acquisition Liability Assigned to Loan Payable	0	64,937
Acquisition Liability Assigned to Promissory Note	0	25,000
Equipment purchase under capital lease	20,399	0
Accrued Interest converted to Note	$ 75,039	$ 0

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Summary of Significant Accounting Policies	Note 1. Organization and Summary of Significant Accounting Policies Organization and Basis of Presentation Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent diagnostic imaging facility located in Pottsville, Pennsylvania. In 2014, the company purchased Partners Imaging Center of Venice, LLC (“PIV”) located in Venice, Florida; Partners Imaging Center of Naples, LLC (“PIN”) located in Naples, Florida; and Partners Imaging Center of Charlotte, LLC (“PIC”) located in Port Charlotte, Florida. Basis of Presentation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31. Principle of Consolidation The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, CTS, SMI, PIV, PIN, and PIC Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’, SMI’s, PIV’s, PIN’s, and PIC’s accumulated earnings prior to their acquisitions (March 2, 2009, December 10, 2012, and November 1, 2014, respectively) are not included in the consolidated balance sheet. Reclassification of Accounts Certain prior period amounts have been reclassified to conform to the June 30, 2015 presentation. Use of Estimates and Assumptions The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At June 30, 2015, and December 31, 2014, cash includes cash on hand and cash in the bank. Accounts Receivable Credit Risk The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio. Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables. As of June 30, 2015 and December 31, 2014, the allowance for bad debts was $71,052 and $64,673, respectively. Bad debt expense for the three months ended June 30, 2015 and 2014 was $6,379 and $7,458, respectively. Bad debt expense for the six months ended June 30, 2015 and 2014 was $6,379 and $14,980, respectively. As of June 30, 2015 two customers of CTS totalled approximately 13% of the total accounts receivable. As of December 31, 2014, three customers totalled approximately 16% of the total accounts receivable. Goodwill and Indefinite Intangible Assets The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets Revenue Recognition The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the six months ended June 30, 2015, CTS held six contracts; one contract that is renewable on a year-to-year basis, three contracts that are renewable in 2015, and 2016, and its largest contract, which renewed automatically in 2014 for successive one year terms. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy). Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, Revenue Recognition – Principal Agent Considerations For SMI, PIV, PIN, and PIC revenue is recorded at the time of service Cost of Sales Cost of sales includes fees paid to radiologists for reading services, transcription fees, equipment repairs, system license and usage costs. Impairment of Long-Lived Assets In accordance with ASC Topic 360, Property, Plant and Equipment, Amortization and Depreciation Depreciation and amortization are calculated using the straight-line method over the following useful lives: 3 - 7 years Equipment 5 – 7 years Furniture and Fixtures 3 - 5 years Non-compete Contract 39 years Leasehold Improvements Stock Based Compensation The company follows ASC 718 to produce an estimated fair value. The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Binomial option pricing model (“BOPM”). The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate. The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the BOPM on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received. The Company did not recognized stock-based compensation expenses from stock options to non-employees for the three months ended June 30, 2015 and 2014. The Company recognized stock-based compensation expenses of $34,683 and $0 from stock options granted to non-employees for the six months ended June 30, 2015 and 2014. The stock based compensation for the six months ended June 30, 2015 pertains to stock options granted to non-employee. The options were valued using the BOPM and included in the Legal and professional operating expenses in the consolidated statements of operations. The Company recognized stock-based compensation expenses of $0 from stock and stock options granted to employees for the three months ended June 30, 2015, and 2014, respectively. The Company recognized stock-based compensation expenses of $58,236, and $150 from stock and stock options granted to employees for the six months ended June 30, 2015, and 2014, respectively. The stock based compensation for the six months ended June 30, 2015 includes stock options granted to employees of $47,896. The options were valued using the BOPM and included in the Labor and management fees operating expenses in the consolidated statements of operations for $34,683, and $13,213, respectively. Fair Value of Financial Instruments The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation. The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities. Fair Value Measurements The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments. The company does not have assets and liabilities that are carried at fair value on a recurring basis. Foreign Currency Translation The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity. The Company recognized a foreign currency loss on transactions from operations of $19,755 and foreign currency gain of $394 for the three months ended June 30, 2015 and 2014, respectively. The Company recognized a foreign currency loss on transactions from operations of $17,519 and foreign currency gain of $809 for the six months ended June 30, 2015 and 2014, respectively. The Company recognized other comprehensive gain of $37,654 and loss of $1,336 for the three months ended June 30, 2015 and 2014, respectively. The Company recognized other comprehensive gain of $57,051 and loss of $271 for the six months ended June 30, 2015 and 2014, respectively. Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Net Income (Loss) Per Share The Company follows the provisions of ASC Topic 260, Earnings per Share Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive. The information related to basic and diluted earnings per share is as follows: Three Months Ended Six Months Ended June 30, 2015 June 30, 2014 June 30, 2015 June 30, 2014 Numerator: Continuing operations: Total Comprehensive Income (Loss) $ 23,864 $ (10,336) $ (342,710) $ (49,546) Total $ 23,864 $ (10,336) $ (342,710) $ (49,546) Total Comprehensive Income (Loss) $ 23,864 $ (10,336) $ (342,710) $ (49,546) Denominator: Weighted average number of shares outstanding – basic and diluted 24,166,481 23,767,195 24,131,342 23,605,790 EPS: Basic: Total Comprehensive Income (Loss) $ 0.001 $ (0.00) $ (0.014) $ (0.002) Net Income (loss) $ 0.001 $ (0.00) $ (0.014) $ (0.002) Diluted Total Comprehensive Income (Loss) $ 0.001 $ (0.00) $ (0.014) $ (0.002) Total Comprehensive Income (Loss) $ 0.001 $ (0.00) $ (0.014) $ (0.002) Recent Accounting Updates The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Interim Financial Statements

Interim Financial Statements	6 Months Ended
	Jun. 30, 2015
Quarterly Financial Information Disclosure [Abstract]
Interim Financial Statements	Note 2. Interim Financial Statements The accompanying interim unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six month period ended June 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2015
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 3. Property and Equipment For the six months ended, June 30, 2015 the company has acquired additional computer equipment of $ 33,109 for its CTS subsidiary and additional medical imaging equipment hardware of $30,096 for its PIV subsidiary. For the year ended December 31, 2014, the Company has completed the purchase of a CT and an X-ray machine for its SMI location. SMI has purchased a 16 Slice Toshiba Aquillion CT for $198,000 and a Viztek Digital Direct Radiography Straight Arm x-ray System for $78,250. In addition SMI has completed building CT and x-ray rooms to house the additional machines; the additions in leasehold improvements were for a total of $96,470. SMI has acquired a new PACS/RIS system for $162,333. As part of the November 1, 2014 acquisitions of PIV, PIN, and PIC clinics the company has acquired Medical equipment of $1,245,000. For the year ended December 31, 2014 the company has acquired additional computer equipment of $25,108 for its PIV, PIN, PIN location, as well as a new PACS/RIS system for $167,107. Property and equipment are stated at cost. Depreciation is calculated using the straight - line method over the estimated useful life of the assets. At June 30, 2015 and December 31, 2014, the major class of property and equipment were as follows: June 30, 2015 December 31, 2014 Estimated useful lives Computer/Office Equipment $ 464,313 $ 435,867 3-7 years Medical Equipment 2,153,121 2,123,023 3-7 years Leasehold Improvements 843,781 843,781 39 years Less: Accumulated Depreciation (732,133) (463,977) Net Book Value $ 2,729,082 $ 2,938,694 Depreciation expense was $137,014 and $39,835 for the three months ended June 30, 2015 and 2014, respectively. Depreciation expense was $272,738 and $79,655 for the six months ended June 30, 2015 and 2014, respectively.

Business Combination

Business Combination	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Business Combination	Note 4. Business Combination On October 31, 2014, the Company acquired 100% of the shares of three separate entities, Partners Imaging Center of Venice, LLC, Partners Imaging Center of Naples, LLC, and Partners Imaging Center of Charlotte, LLC., for an aggregate cash consideration described in detail below. Each company was purchased for its medical equipment, general office fixtures, Medicare number and facility lease. There were no prior earnings, accounts receivable, accounts payable, or other assets or liabilities acquired in any of the acquisitions. Medical imaging services began to be offered on November 1, 2014 by PIV, PIN, and PIC. The Company paid an aggregate purchase price of $1,800,000 as follows (at fair value): Total PIV PIN PIC Cash $ 1,800,000 959,286 533,571 307,143 Total consideration paid $ 1,800,000 959,286 533,571 307,143 The following assets and liabilities were recognized (at fair value): Total PIV PIN PIC Fixed Assets $ 1,245,000 695,000 375,000 175,000 Goodwill 555,000 264,286 158,571 132,143 Net assets purchased $ 1,800,000 959,286 533,571 307,143 The Company has evaluated the transactions and believes that the historical cost of the tangible and intangible assets acquired approximated the fair market value given the current nature of the assets acquired. As part of the acquisitions the company has acquired aggregate Goodwill of $555,000. The company expects to amortize the full amounts of goodwill for tax purposes. The company will perform annual testing of goodwill for impairment. The amounts of revenue and gross earnings included in the consolidated income statement for the Six months ended June 30, 2015 and 2014 are as follow: Six Months Ended June 30, 2015 Total PIV PIN PIC Revenue $ 1,680,037 788,187 412,253 479,597 Gross Earnings $ 1,029,098 459,279 259,092 310,727 Six Months Ended June 30, 2014 Total PIV PIN PIC Revenue $ - - - - Gross Earnings $ - - - - Costs related to the acquisitions, which include legal fees, in the aggregate amount of about $29,500 have been charged directly to operations and are included in legal and professional expenses in the 2014 consolidated income statement.

Goodwill

Goodwill	6 Months Ended
	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 5. Goodwill The change in the carrying amount of goodwill for the two years ended June 30, 2015 was: Balance as of January 1, 2014 $ 1,422,670 Acquisition of goodwill during the year 555,000 Changes in goodwill during the year - Balance as of December 31, 2014 1,977,670 Changes in goodwill during the year - Balance as of June 30, 2015 $ 1,977,670

Lease Commitments

Lease Commitments	6 Months Ended
	Jun. 30, 2015
Leases, Operating [Abstract]
Lease Commitments	Note 6. Lease Commitments CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $3,550 in utilities, realty taxes, and operating costs, for a total of approximately $6,000 per month. The Lease renewed in April 2013 for a period of five years and will expire in March 2018. On renewal, CTS was given a rental credit of approximately $28,000. This lease was accounted for as an operating lease. SMI has a lease for its off-site servers at a cost of approximately $1,092 per month. This lease is accounted for as an operating lease on a month-to-month basis. SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. Monthly rental amounts in 2014 were $5,437 per month plus approximately $1,674 in utilities, realty taxes, and operating costs. SMI has a lease for office space in Dallas, Texas of approximately $880 per month plus approximately $660 in utilities, realty taxes, and operating costs. The lease will expire in August 31, 2015. PIV has a lease for office space in Venice, Florida. The lease will expire October 1, 2016. Monthly rental amounts are $14,990 per month. PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020. Monthly rental amounts are $9,543 per month. PIC has a lease for office space in Port Charlotte, Florida. The lease will expire June 20, 2016. Monthly rental amounts are $5,512 per month. Expected Lease commitments for the next three years: Year Office Space Servers Total 2015 $ 261,936 $ 15,552 $ 277,488 2016 412,154 31,104 443,258 2017 186,516 19,104 205,620 $ 860,606 $ 65,760 $ 926,366

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	6 Months Ended
	Jun. 30, 2015
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Note 7. Accounts Payable and Accrued Liabilities As of June 30, 2015 and December 31, 2014, the trade payables and accrued liabilities of the Company were $1,092,204 and $935,688, respectively. Of the total amount as of June 30, 2015, $764,660 was related to ongoing operations representing a balance owing to trade payables. $165,733 was related to accrued payroll and withholdings liabilities, and $161,811 was related to Federal and State income tax owing. Of the total amount as of December 31, 2014, $624,141 was related to ongoing operations representing a balance owing to trade payables. $73,461 was related to accrued payroll and withholdings liabilities, and $238,086 was related to Federal and State income tax owing.

Obligations Under Capital Lease

Obligations Under Capital Lease	6 Months Ended
	Jun. 30, 2015
Leases, Capital [Abstract]
Obligations Under Capital Lease	Note 8. Obligations Under Capital Lease SMI MRI Machines Capital Lease: On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000. The gross amount of the equipment held under capital leases totals $555,000 ($268,333 net book value after accumulated amortization of $286,667) at June 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $27,750 for the three months ended June 30, 2015 and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $55,500 for the six months ended June 30, 2015 and 2014, respectively. SMI X-ray Machine Capital Lease: On July 03, 2014 Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $78,250. The gross amount of the x-ray machine held under the capital lease is $78,250 ($62,600 net book value after accumulated amortization of $15,650) at June 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $3,913, and $0 for the three months ended June 30, 2015 and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $7,827, and $0 for the six months ended June 30, 2015 and 2014, respectively. SMI PACS/RIS System Capital Lease: On August 19, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $3,115, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the system for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $162,333 The gross amount of the PACS/RIS system held under the capital lease is $162,333 ($140,688 net book value after accumulated amortization of $21,644) at June 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $8,117, and $0 for the three months ended June 30, 2015, and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $16,234, and $0 for the six months ended June 30, 2015, and 2014, respectively. PV, PN, PC PACS/RIS Capital Lease: On November 26, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, PIV, is to make monthly payments of $3,094, plus applicable sales tax, over a period of 60 months. At the end of the lease, PIV will have the option to purchase the system for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $167,107. The gross amount of the PACS/RIS system held under the capital lease is $167,107 ($149,003 net book value after accumulated amortization of $18,103) at June 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $8,355, and $0 for the three months ended June 30, 2015, and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $16,710, and $0 for the six months ended June 30, 2015, and 2014, respectively. PV, PN, PC Computers Capital Lease: On December 10, 2014 the company has entered into a capital lease agreement to lease computers that were delivered and installed in December 2014. Under the terms of the lease, the Company is to make monthly payments of $813.16, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $25,108. The gross amount of the computers held under the capital lease is $25,108 ($20,575 net book value after accumulated amortization of $4,533) at June 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $2,092, and $0 for the three months ended June 30, 2015, and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $4,184, and $0 for the six months ended June 30, 2015, and 2014, respectively. CTS Computers Lease On January 21, 2015 the company has entered into a capital lease agreement to lease computers that were installed on the same date of acceptance. Under the terms of the lease, the company is to make monthly payments of $651.43, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $20,399 (amount is carried in Canadian dollar). The gross amount of the computers held under the capital lease is $20,399 ($17,566 net book value after accumulated amortization of $2,833) at June 30, 2015. Amortization of the capital lease assets is included in the depreciation expense of $1,725, and $0 for the three months ended June 30, 2015, and 2014, respectively. Amortization of the capital lease assets is included in the depreciation expense of $2,875, and $0 for the six months ended June 30, 2015, and 2014, respectively. Minimum future lease payments under the capital leases as of June 30, 2015 are as follow: Minimum Lease Payments Total SMI MRI SMI PACS/RIS Lease SMI Xray Lease PV,PN, PC PACS/RIS Lease PV,PN,PC Computers Lease CTS Computers Lease 2015 $ 120,726 66,076 18,690 8,972 18,590 4,879 3,519 2016 241,400 132,152 37,380 17,944 37,128 9,758 7,038 2017 108,435 - 37,380 17,944 37,128 8,945 7,038 2018 93,625 - 37,380 17,944 37,128 - 1,173 2019 83,356 - 34,265 11,963 37,128 - - 2020 3,094 - - - 3,094 - - Total minimum lease payments 650,637 198,228 165,095 74,768 170,196 23,582 18,768 Less amount representing interest 63,202 15,580 19,415 9,186 15,684 2,767 568 Present value of minimum lease payments 587,435 182,648 145,680 65,582 154,512 20,814 18,200 Less current portion of minimum lease payments 208,519 118,551 29,862 14,206 31,211 7,992 6,697 Long-term capital lease obligations $ 378,916 64,096 115,819 51,376 123,301 12,822 11,502

Convertible Notes

Convertible Notes	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Convertible Notes	Note 9. Convertible Notes Series B: On December 3, 2012, the Company sold, through a private placement to accredited investors, three year 12% convertible notes (“Series B Notes”) in the aggregate principal amount of $1,865,000. On March 27, 2013 the Company sold an additional $150,000 of Series B Notes. Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month. The Notes are convertible into common shares of the Company at $0.10 per share. In addition, each holder of Series B Notes received shares dependent on the dollar amount of Notes purchased. The total number of shares issued was 5,315,000 shares of common stock of the Company. $1,865,000 of Series B Notes issued on December 3, 2012 mature on December 31, 2015; and $150,000 of Series B Notes issued March 27, 2013 mature on March 31, 2016. For the six months ended June 30, 2015, $120,900 in accrued interest was recorded on the notes and paid. In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $244,275. Amortization of the discount for the six months ended June 30, 2015 was $40,713. The Details of Series B Notes are as follows: Issuance December 31, December 31, Six Months Six Months Six Months June 30, Maturity Date 2014 2014 Ended Ended Ended 2015 Date Balance Unamortized June 30, June 30, June 30, Balance, net Discount 2015 2015 2015 Beginning Interest (Payments) Amortization Balance Accrued of Debt Discount 03-Dec-12 $ 25,000 $ (344) $ 1,500 $ (1,500) $ 188 $ 24,844 31-Dec-15 03-Dec-12 125,000 (5,594) 7,500 (7,500) 2,487 121,894 31-Dec-15 03-Dec-12 50,000 (1,031) 3,000 (3,000) 563 49,531 31-Dec-15 03-Dec-12 25,000 (344) 1,500 (1,500) 188 24,844 31-Dec-15 03-Dec-12 25,000 (344) 1,500 (1,500) 188 24,844 31-Dec-15 03-Dec-12 25,000 (344) 1,500 (1,500) 188 24,844 31-Dec-15 03-Dec-12 1,500,000 (61,875) 90,000 (90,000) 33,750 1,471,875 31-Dec-15 03-Dec-12 50,000 (1,031) 3,000 (3,000) 563 49,530 31-Dec-15 03-Dec-12 15,000 (206) 900 (900) 113 14,906 31-Dec-15 03-Dec-12 100,000 (3,656) 6,000 (6,000) 1,711 98,056 31-Dec-15 27-Mar-13 25,000 (646) 1,500 (1,500) 258 24,613 31-Mar-16 27-Mar-13 25,000 (646) 1,500 (1,500) 258 24,613 31-Mar-16 27-Mar-13 25,000 (646) 1,500 (1,500) 258 24,613 31-Mar-16 Total $ 2,015,000 $ (76,706) $ 120,900 $ (120,900) $ 40,713 $ 1,979,007 Following are maturities of the long –term debt in Series B Notes for each of the next 5 years: Principal Payments Interest Payments Amortization of Discount 2015 $ 1,865,000 $ 120,900 $ 34,443 2016 150,000 4,500 1,550 2017 - - - 2018 - - - 2019 - - - Total $ 2,015,000 $ 125,400 $ 35,993 Series C: On May 22, 2014 the Company sold, through private placement to accredited investors, three year 12% convertible notes (“Series C Notes”) in the aggregate principal amount of $95,000. The Notes bear interest at a rate of 12% per annum, payable to the holder at1% per month, with the principal amount due on May 31, 2017. The Notes are convertible into shares of the Company’s common stock at an initial conversion rate of $0.15 per share. In addition, each holder of Series C Notes received shares dependent on the dollar amount of Notes purchased. On August 25, 2014, October 31, 2014 and February 17, 2015 the company sold an additional $75,000, $50,000 and $20,000, respectively of “series C notes”. The total number of shares issued was 240,000 shares of common stock of the Company. In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $12,695. Amortization of the discount for the six months ended June 30, 2015 was $2,496. For the six months ended June 30, 2015, $14,000 in accrued interest was recorded on the notes and paid. Issuance December 31, Six Months December 31, Six Months Six Months Six Months June 30, Maturity Date 2014 Ended 2014 Ended Ended Ended 2015 Date Balance June 30, Unamortized June 30, June 30, June 30, Balance, net 2015 Discount 2015 2015 2015 Proceeds Beginning Interest (Payments) Amortization Balance Accrued of Debt Discount 22-May-14 $ 50,000 $ - $ (2,417) $ 3,000 $ (3,000) $ 500 $ 48,083 31-May-17 22-May-14 22,500 - (1,088) 1,350 (1,350) 225 21,638 31-May-17 22-May-14 22,500 - (1,088) 1,350 (1,350) 225 21,638 31-May-17 25-Aug-14 50,000 - (3,419) 3,000 (3,000) 662 47,243 31-October-17 25-Aug-14 25,000 - (1,709) 1,500 (1,500) 331 23,622 31-October-17 31-Oct-14 50,000 - (2,479) 3,000 (3,000) 438 47,957 31-October-17 17-Feb-15 - 20,000 (1,040) 800 (800) 116 19,076 17-February-18 Total $ 220,000 $ 20,000 $ (13,239) $ 14,000 $ (14,000) $ 2,496 $ 229,257 Following are maturities of the long –term debt in Series C Notes for each of the next 5 years: Principal Payments Interest Payments Amortization of Discount 2015 $ - $ 14,400 $ 2,380 2016 - 24,400 4,876 2017 220,000 12,650 3,429 2018 20,000 400 58 2019 - - - Total $ 240,000 $ 51,850 $ 10,743 Individually issued Convertible Note: On March 26, 2014 the Company issued $300,000 in convertible note to a non-affiliate. The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. In addition to interest payments the Company will be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for three years until the note due date of February 27, 2017. The note is convertible into common shares of the Company at $0.15 per share. In addition, the non-affiliate will receive 300,000 shares as part of the note agreement. For the six months ended June 30, 2015, $14,725 in accrued interest was recorded on the notes and paid. In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $25,500. Amortization of the discount for the six months ended June 30, 2015 was $4,250. Summary of the note is as follows: June 30, 2015 December 31, 2014 Convertible note Beginning Balance $ 260,000 $ 300,000 Less: unamortized debt discount (14,875) (19,125) Convertible notes principal, net 245,125 280,875 Less: Payments in Period (44,725) (66,504) Added: Accrued interest 14,725 26,504 Total Convertible note, net $ 215,125 $ 240,875 Less: short term portion, net 56,120 54,263 Long term portion, net $ 159,005 $ 186,612 Following are maturity of the individually issued convertible note for each of the next 5 years: Principal Payments Interest Payments Amortization of Discount 2015 $ 30,000 $ 20,339 $ 6,375 2016 60,000 20,748 8,500 2017 140,000 2,625 2,125 2018 - - - 2019 - - - Total $ 230,000 $ 43,712 $ 17,000

Promissory Notes

Promissory Notes	6 Months Ended
	Jun. 30, 2015
Other Liabilities Disclosure [Abstract]
Promissory Notes	Note 10. Promissory Notes In June 2014 $64,937 of the SMI acquisition liability that was due as part of SMI acquisition was assigned to a promissory note accruing interest at an annual rate of 12%, and due on February 1, 2015. Interest accrued is to be paid out monthly with the principal amount due on maturity. The note has been fully paid in February 2015. In December 2014, the company issued a short term loan payable to a non-related party for $50,000 in proceeds. The note is due on demand and does not accrue interest. For the six months ended June 30, 2015 the company made payments of $54,000 towards the balance and has received additional proceeds of $4,000. As of June 30, 2015 the loan is paid out in full. For the six months ended June 30, 2015 the company has issued loans total of $720,000, the loans terms call for weekly payments of $28,000 towards the principal balance and interest. The final payment is due August 18, 2015. In June 2015 the company has issued a loan of $120,700, the loan terms call for a daily payment of $453, towards the principal balance and interest. The final payment is due July 7, 2016. In June 2015 the company has issued a loan of $163,362, the loan terms call for a daily payment of $613, towards the principal balance and interest. The final payment is due July 7, 2016. Amounts are carried in Canadian Dollars. A summary of the promissory notes is as follows: Promissory notes at January 1, 2014 $ 45,015 Added: Note assigned through December 31, 2014 64,937 Added: Accrued Interest through December 31, 2014 6,069 Added: Proceeds through December 31, 2014 50,000 Less: Payments through December 31, 2014 (31,022) Promissory notes at December 31, 2014 $ 134,999 Added: Accrued Interest through June 30, 2015 496 Added: Proceeds through June 30, 2015 1,008,063 Less: Payments through June 30, 2015 (662,787) Added: Discount through June 30, 2015 (99,502) Promissory notes at June 30, 2015 $ 381,269 Less: Short term portion 381,269 Long term portion June 30, 2015 $ -

Royalty Financing

Royalty Financing	6 Months Ended
	Jun. 30, 2015
Royalty Financing
Royalty Financing	Note 11. Royalty Financing On October 31, 2014 the company entered into a royalty purchase agreement with Grenville Strategic Royalty Corp. for the amount of $2,000,000. The agreement calls for a monthly payment to the seller based on a percentage of the total of certain revenue items, and subject to a minimum payment amount. For the six months ended June 30, 2015 the company paid a total of $241,203 in royalty payments. The amount financed is recorded net of discount to be amortized of the term. As of June 30, 2015 the company has recorded discount amortization expense of $228,826. The balance as shown on the consolidated balance sheet as of June 30, 2015 is $1,987,623.

Major Customers

Major Customers	6 Months Ended
	Jun. 30, 2015
Major Customers
Major Customers	Note 12. Major Customers For the six months ending June 30, 2015 and 2015, revenue was derived primarily from radiology services. Major customers representing more than 10% of total revenue for the six months ended June 30, 2015 and 2014 are as follow: Six Months Ended Six Months Ended June 30, 2015 June 30, 2014 Customers Revenue amount Revenue percentage Revenue amount Revenue percentage Contract A $ - 0% $ 529,754 21% Contract E 436,666 12% 455,253 18% Contract F 262,019 7% 279,189 11% Contract H $ 157,695 4% $ 149,408 6% There were no closing balances for accounts receivable greater than 10% of total balance.

Major Vendors

Major Vendors	6 Months Ended
	Jun. 30, 2015
Major Vendors
Major Vendors	Note 13. Major Vendors The company has one major vendor providing its system software and support. Expenses relating to this vendor for the three months ended June 30, 2015 and 2014 were $14,040 and $12,569, respectively.

Common Stock Transactions

Common Stock Transactions	6 Months Ended
	Jun. 30, 2015
Equity [Abstract]
Common Stock Transactions	Note 14. Common Stock Transactions On January 27, 2015 the company granted options as considerations for services provided by the CEO of the company. The options are to purchase up to 4,200,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $34,683. On January 27, 2015 the company granted options as considerations for consulting services provided to the company. The options are to purchase up to 4,200,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $34,683. On January 27, 2015 the company granted options as considerations for services provided by the CFO of the company. The options are to purchase up to 1,600,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $13,213. For the six months ended June 30, 2015, 200,000 shares were issued for services valued at $10,340 based upon the closing price of our common stock at the grant date. For the six months ended June 30, 2015, 20,000 shares were issued as part of series C convertible note agreements. The shares were valued at $1,040 based upon the closing price of our common stock at the grant date. For the year ended December 31, 2014, 5,000 shares were issued for services valued at $150 based upon the closing price of our common stock at the grant date. For the year ended December 31, 2014, 300,000 shares were issued as part of individually issued convertible note agreements. The shares were valued at $25,500 based upon the closing price of our common stock at the grant date. For the year ended December 31, 2014, 220,000 shares were issued as part of series C convertible note agreements. The shares were valued at $14,280 based upon the closing price of our common stock at the grant date.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Note 15. Income Tax The Company follows ASC 740, Income Taxes The provisions of ASC 740 require companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure. Management does not believe that the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense.

Going Concern

Going Concern	6 Months Ended
	Jun. 30, 2015
Going Concern
Going Concern	Note. 16. Going Concern As shown in the accompanying consolidated financial statements, the company incurred net loss of $342,710 for the six months ended June 30, 2015, as well as a working capital deficit of $2,434,102. These conditions raise substantial doubt as to if the company’s ability to continue as a going concern. Management plan to raise additional financing in order to continue its operations and fulfil its debt obligations in 2015, but there can be no assurances that the plan will be successful. These consolidated financial statements do not include any adjustments that might be necessary if the company is unable to continue as a going concern.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 17. Subsequent events Subsequent to quarter end, the company sold loans in the aggregate principal amount of $260,000. The Company evaluated subsequent events through the date the consolidated financial statements were issued.

Accounting Policies (Policies)

Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Organization and Basis of Presentation	Organization and Basis of Presentation Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent diagnostic imaging facility located in Pottsville, Pennsylvania. In 2014, the company purchased Partners Imaging Center of Venice, LLC (“PIV”) located in Venice, Florida; Partners Imaging Center of Naples, LLC (“PIN”) located in Naples, Florida; and Partners Imaging Center of Charlotte, LLC (“PIC”) located in Port Charlotte, Florida. Basis of Presentation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Principle of Consolidation	Principle of Consolidation The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, CTS, SMI, PIV, PIN, and PIC Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’, SMI’s, PIV’s, PIN’s, and PIC’s accumulated earnings prior to their acquisitions (March 2, 2009, December 10, 2012, and November 1, 2014, respectively) are not included in the consolidated balance sheet.
Reclassification of Accounts	Reclassification of Accounts Certain prior period amounts have been reclassified to conform to the June 30, 2015 presentation.
Use of Estimates and Assumptions	Use of Estimates and Assumptions The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Accounts Receivable Credit Risk	Accounts Receivable Credit Risk The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio. Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables.
Goodwill and Indefinite Intangible Assets	Goodwill and Indefinite Intangible Assets The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets
Revenue Recognition	Revenue Recognition The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy). Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, Revenue Recognition – Principal Agent Considerations For SMI, PIV, PIN, and PIC revenue is recorded at the time of service
Cost of Sales	Cost of Sales Cost of sales includes fees paid to radiologists for reading services, transcription fees, equipment repairs, system license and usage costs.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets In accordance with ASC Topic 360, Property, Plant and Equipment,
Amortization and Depreciation	Amortization and Depreciation Depreciation and amortization are calculated using the straight-line method over the following useful lives: 3 - 7 years Equipment 5 – 7 years Furniture and Fixtures 3 - 5 years Non-compete Contract 39 years Leasehold Improvements
Stock Based Compensation	Stock Based Compensation The company follows ASC 718 to produce an estimated fair value. The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Binomial option pricing model (“BOPM”). The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate. The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the BOPM on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation. The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
Fair Value Measurements	Fair Value Measurements The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments. The company does not have assets and liabilities that are carried at fair value on a recurring basis.
Foreign Currency Translation	Foreign Currency Translation The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes
Net Income (Loss) Per Share	Net Income (Loss) Per Share The Company follows the provisions of ASC Topic 260, Earnings per Share Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive.
Recent Accounting Updates	Recent Accounting Updates The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Organization and Summary of S24

Organization and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Earnings Per Share	Three Months Ended Six Months Ended June 30, 2015 June 30, 2014 June 30, 2015 June 30, 2014 Numerator: Continuing operations: Total Comprehensive Income (Loss) $ 23,864 $ (10,336) $ (342,710) $ (49,546) Total $ 23,864 $ (10,336) $ (342,710) $ (49,546) Total Comprehensive Income (Loss) $ 23,864 $ (10,336) $ (342,710) $ (49,546) Denominator: Weighted average number of shares outstanding – basic and diluted 24,166,481 23,767,195 24,131,342 23,605,790 EPS: Basic: Total Comprehensive Income (Loss) $ 0.001 $ (0.00) $ (0.014) $ (0.002) Net Income (loss) $ 0.001 $ (0.00) $ (0.014) $ (0.002) Diluted Total Comprehensive Income (Loss) $ 0.001 $ (0.00) $ (0.014) $ (0.002) Total Comprehensive Income (Loss) $ 0.001 $ (0.00) $ (0.014) $ (0.002)

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2015
Property, Plant and Equipment [Abstract]
Property Plant and Equipment	June 30, 2015 December 31, 2014 Estimated useful lives Computer/Office Equipment $ 464,313 $ 435,867 3-7 years Medical Equipment 2,153,121 2,123,023 3-7 years Leasehold Improvements 843,781 843,781 39 years Less: Accumulated Depreciation (732,133) (463,977) Net Book Value $ 2,729,082 $ 2,938,694

Business Combination (Tables)

Business Combination (Tables)	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Schedule of Purchase Price Allocation	Total PIV PIN PIC Cash $ 1,800,000 959,286 533,571 307,143 Total consideration paid $ 1,800,000 959,286 533,571 307,143
Schedule of Recognized Assets Acquired and Liabilities Assumed	Total PIV PIN PIC Fixed Assets $ 1,245,000 695,000 375,000 175,000 Goodwill 555,000 264,286 158,571 132,143 Net assets purchased $ 1,800,000 959,286 533,571 307,143
Schedule of Revenue and Gross Earnings from Acquired Assets	Six Months Ended June 30, 2015 Total PIV PIN PIC Revenue $ 1,680,037 788,187 412,253 479,597 Gross Earnings $ 1,029,098 459,279 259,092 310,727 Six Months Ended June 30, 2014 Total PIV PIN PIC Revenue $ - - - - Gross Earnings $ - - - -

Goodwill (Tables)

Goodwill (Tables)	6 Months Ended
	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Balance as of January 1, 2014 $ 1,422,670 Acquisition of goodwill during the year 555,000 Changes in goodwill during the year - Balance as of December 31, 2014 1,977,670 Changes in goodwill during the year - Balance as of June 30, 2015 $ 1,977,670

Lease Commitments (Tables)

Lease Commitments (Tables)	6 Months Ended
	Jun. 30, 2015
Leases, Operating [Abstract]
Schedule of Lease Commitments	Year Office Space Servers Total 2015 $ 261,936 $ 15,552 $ 277,488 2016 412,154 31,104 443,258 2017 186,516 19,104 205,620 $ 860,606 $ 65,760 $ 926,366

Obligations Under Capital Lea29

Obligations Under Capital Lease (Tables)	6 Months Ended
	Jun. 30, 2015
Leases, Capital [Abstract]
Schedule of Future Minimum Lease Payments for Capital Leases	Minimum Lease Payments Total SMI MRI SMI PACS/RIS Lease SMI Xray Lease PV,PN, PC PACS/RIS Lease PV,PN,PC Computers Lease CTS Computers Lease 2015 $ 120,726 66,076 18,690 8,972 18,590 4,879 3,519 2016 241,400 132,152 37,380 17,944 37,128 9,758 7,038 2017 108,435 - 37,380 17,944 37,128 8,945 7,038 2018 93,625 - 37,380 17,944 37,128 - 1,173 2019 83,356 - 34,265 11,963 37,128 - - 2020 3,094 - - - 3,094 - - Total minimum lease payments 650,637 198,228 165,095 74,768 170,196 23,582 18,768 Less amount representing interest 63,202 15,580 19,415 9,186 15,684 2,767 568 Present value of minimum lease payments 587,435 182,648 145,680 65,582 154,512 20,814 18,200 Less current portion of minimum lease payments 208,519 118,551 29,862 14,206 31,211 7,992 6,697 Long-term capital lease obligations $ 378,916 64,096 115,819 51,376 123,301 12,822 11,502

Convertible Notes (Tables)

Convertible Notes (Tables)	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt	Series B Issuance December 31, December 31, Six Months Six Months Six Months June 30, Maturity Date 2014 2014 Ended Ended Ended 2015 Date Balance Unamortized June 30, June 30, June 30, Balance, net Discount 2015 2015 2015 Beginning Interest (Payments) Amortization Balance Accrued of Debt Discount 03-Dec-12 $ 25,000 $ (344) $ 1,500 $ (1,500) $ 188 $ 24,844 31-Dec-15 03-Dec-12 125,000 (5,594) 7,500 (7,500) 2,487 121,894 31-Dec-15 03-Dec-12 50,000 (1,031) 3,000 (3,000) 563 49,531 31-Dec-15 03-Dec-12 25,000 (344) 1,500 (1,500) 188 24,844 31-Dec-15 03-Dec-12 25,000 (344) 1,500 (1,500) 188 24,844 31-Dec-15 03-Dec-12 25,000 (344) 1,500 (1,500) 188 24,844 31-Dec-15 03-Dec-12 1,500,000 (61,875) 90,000 (90,000) 33,750 1,471,875 31-Dec-15 03-Dec-12 50,000 (1,031) 3,000 (3,000) 563 49,530 31-Dec-15 03-Dec-12 15,000 (206) 900 (900) 113 14,906 31-Dec-15 03-Dec-12 100,000 (3,656) 6,000 (6,000) 1,711 98,056 31-Dec-15 27-Mar-13 25,000 (646) 1,500 (1,500) 258 24,613 31-Mar-16 27-Mar-13 25,000 (646) 1,500 (1,500) 258 24,613 31-Mar-16 27-Mar-13 25,000 (646) 1,500 (1,500) 258 24,613 31-Mar-16 Total $ 2,015,000 $ (76,706) $ 120,900 $ (120,900) $ 40,713 $ 1,979,007 Series C Issuance December 31, Six Months December 31, Six Months Six Months Six Months June 30, Maturity Date 2014 Ended 2014 Ended Ended Ended 2015 Date Balance June 30, Unamortized June 30, June 30, June 30, Balance, net 2015 Discount 2015 2015 2015 Proceeds Beginning Interest (Payments) Amortization Balance Accrued of Debt Discount 22-May-14 $ 50,000 $ - $ (2,417) $ 3,000 $ (3,000) $ 500 $ 48,083 31-May-17 22-May-14 22,500 - (1,088) 1,350 (1,350) 225 21,638 31-May-17 22-May-14 22,500 - (1,088) 1,350 (1,350) 225 21,638 31-May-17 25-Aug-14 50,000 - (3,419) 3,000 (3,000) 662 47,243 31-October-17 25-Aug-14 25,000 - (1,709) 1,500 (1,500) 331 23,622 31-October-17 31-Oct-14 50,000 - (2,479) 3,000 (3,000) 438 47,957 31-October-17 17-Feb-15 - 20,000 (1,040) 800 (800) 116 19,076 17-February-18 Total $ 220,000 $ 20,000 $ (13,239) $ 14,000 $ (14,000) $ 2,496 $ 229,257
Schedule of Long-term Debt Instruments	June 30, 2015 December 31, 2014 Convertible note Beginning Balance $ 260,000 $ 300,000 Less: unamortized debt discount (14,875) (19,125) Convertible notes principal, net 245,125 280,875 Less: Payments in Period (44,725) (66,504) Added: Accrued interest 14,725 26,504 Total Convertible note, net $ 215,125 $ 240,875 Less: short term portion, net 56,120 54,263 Long term portion, net $ 159,005 $ 186,612
Schedule of Maturities of Long-term Debt	Series B Principal Payments Interest Payments Amortization of Discount 2015 $ 1,865,000 $ 120,900 $ 34,443 2016 150,000 4,500 1,550 2017 - - - 2018 - - - 2019 - - - Total $ 2,015,000 $ 125,400 $ 35,993 Series C Principal Payments Interest Payments Amortization of Discount 2015 $ - $ 14,400 $ 2,380 2016 - 24,400 4,876 2017 220,000 12,650 3,429 2018 20,000 400 58 2019 - - - Total $ 240,000 $ 51,850 $ 10,743 Individually Issued Principal Payments Interest Payments Amortization of Discount 2015 $ 30,000 $ 20,339 $ 6,375 2016 60,000 20,748 8,500 2017 140,000 2,625 2,125 2018 - - - 2019 - - - Total $ 230,000 $ 43,712 $ 17,000

Promissory Notes (Tables)

Promissory Notes (Tables)	6 Months Ended
	Jun. 30, 2015
Other Liabilities Disclosure [Abstract]
Schedule of Promissory Notes	Promissory notes at January 1, 2014 $ 45,015 Added: Note assigned through December 31, 2014 64,937 Added: Accrued Interest through December 31, 2014 6,069 Added: Proceeds through December 31, 2014 50,000 Less: Payments through December 31, 2014 (31,022) Promissory notes at December 31, 2014 $ 134,999 Added: Accrued Interest through June 30, 2015 496 Added: Proceeds through June 30, 2015 1,008,063 Less: Payments through June 30, 2015 (662,787) Added: Discount through June 30, 2015 (99,502) Promissory notes at June 30, 2015 $ 381,269 Less: Short term portion 381,269 Long term portion June 30, 2015 $ -

Major Customers (Tables)

Major Customers (Tables)	6 Months Ended
	Jun. 30, 2015
Major Customers
Schedule of Revenue by Major Customers	Six Months Ended Six Months Ended June 30, 2015 June 30, 2014 Customers Revenue amount Revenue percentage Revenue amount Revenue percentage Contract A $ - 0% $ 529,754 21% Contract E 436,666 12% 455,253 18% Contract F 262,019 7% 279,189 11% Contract H $ 157,695 4% $ 149,408 6%

Organization and Summary of S33

Organization and Summary of Significant Accounting Policies - Basic and Diluted Earners Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Numerator
Total comprehensive income (loss)	$ 23,864	$ (10,336)	$ (342,710)	$ (49,546)
Denominator
Weighted average number of shares outstanding - basic and diluted	24,166,481	23,767,195	24,131,342	23,605,790
Earnings per Share
Basic earnings per share from total comprehensive income (loss)	$ 0.001	$ 0	$ (0.014)	$ (0.002)
Diluted earnings per share from total comprehensive income (loss)	$ 0.001	$ 0	$ (0.014)	$ (0.002)

Organization and Summary of S34

Organization and Summary of Significant Accounting Policies - PPE Amortization and Depreciation (Details Narrative)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Equipment
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	3 - 7 years
Furniture and Fixtures
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	5 - 7 years
Non-compete Contract
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	3 - 5 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	39 years	39 years

Organization and Summary of S35

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Accounts Receivable, Net, Current
Allowance for bad debts	$ 71,052		$ 71,052		$ 64,673
Bad debt expense (recapture)	6,379	$ 7,458	$ 6,379	$ 14,980
Accounts receivable, concentration risk			13.00%		16.00%
Goodwill and Indefinite Intangible Assets
Goodwill	1,977,670		$ 1,977,670		$ 1,977,670	$ 1,422,670
Recognized Share-Based Compensation Expense
Stock-based compensation expense, non-employees			34,683	0
Stock-based compensation expense, employees	0	0	58,236	150
Stock options granted to employees			47,896
Labor and management fees			34,683	13,213
Other Income and (Expenses):
Foreign currency gains (losses)	(19,755)	394	(17,519)	809
Other comprehensive income (loss)	37,654	$ (1,336)	57,051	$ (271)
Contract-Based Intangible Assets | SMI
Goodwill and Indefinite Intangible Assets
Goodwill	1,422,670		1,422,670
Contract-Based Intangible Assets | PIC
Goodwill and Indefinite Intangible Assets
Goodwill	132,143		132,143
Contract-Based Intangible Assets | PIN
Goodwill and Indefinite Intangible Assets
Goodwill	158,571		158,571
Contract-Based Intangible Assets | PIV
Goodwill and Indefinite Intangible Assets
Goodwill	$ 264,286		$ 264,286

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,461,215	$ 3,402,671
Property and equipment, accumulated depreciation	732,133	463,977
Property and equipment, net	2,729,082	2,938,694
Computer/Office Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 464,313	$ 435,867
Property and equipment, estimated useful lives	3-7 years	3-7 years
Medical Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,153,121	$ 2,123,023
Property and equipment, estimated useful lives	3-7 years	3-7 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 843,781	$ 843,781
Property and equipment, estimated useful lives	39 years	39 years

Property and Equipment (Detai37

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Depreciation expense	$ 137,014	$ 39,835	$ 272,738	$ 79,655
Computer/Office Equipment
Payments to acquire equipment					$ 192,215
Computer/Office Equipment | CTS
Payments to acquire equipment			33,109
Medical Equipment
Payments to acquire equipment			$ 30,096		1,245,000
Medical Equipment | SMI
Payments to acquire equipment					438,583
Leasehold improvements					$ 96,470

Business Combination - Consider

Business Combination - Consideration Transfered (Details)	12 Months Ended
	Dec. 31, 2014USD ($)
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	$ 1,800,000
Total consideration paid	1,800,000
PIV
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	959,286
Total consideration paid	959,286
PIN
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	533,571
Total consideration paid	533,571
PIC
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	307,143
Total consideration paid	$ 307,143

Business Combination - Recogniz

Business Combination - Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)	Dec. 31, 2014USD ($)
Business Acquisition [Line Items]
Fair value fixed assets	$ 1,245,000
Fair value goodwill	555,000
Fair value net assets purchased	1,800,000
PIV
Business Acquisition [Line Items]
Fair value fixed assets	695,000
Fair value goodwill	264,286
Fair value net assets purchased	959,286
PIN
Business Acquisition [Line Items]
Fair value fixed assets	375,000
Fair value goodwill	158,571
Fair value net assets purchased	533,571
PIC
Business Acquisition [Line Items]
Fair value fixed assets	175,000
Fair value goodwill	132,143
Fair value net assets purchased	$ 307,143

Business Combination - Revenue

Business Combination - Revenue and Gross Earnings (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Business Acquisition [Line Items]
Revenue from business combination	$ 1,680,037	$ 0
Gross Earnings from business combination	1,029,098	0
PIV
Business Acquisition [Line Items]
Revenue from business combination	788,187	0
Gross Earnings from business combination	459,279	0
PIN
Business Acquisition [Line Items]
Revenue from business combination	412,253	0
Gross Earnings from business combination	259,092	0
PIC
Business Acquisition [Line Items]
Revenue from business combination	479,597	0
Gross Earnings from business combination	$ 310,727	$ 0

Business Combination (Details N

Business Combination (Details Narrative) - Dec. 31, 2014 - USD ($)	Total
Business Combinations [Abstract]
Share Purchase Agreement, purchase price	$ 1,800,000
Business combination, costs related to the acquisition	29,500
Business combination, goodwill	$ 555,000

Goodwill (Details)

Goodwill (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Goodwill [Roll Forward]
Goodwill, balance at beginning of period	$ 1,977,670	$ 1,422,670
Changes in Goodwill	0	0
Goodwill, Acquired During Period	0	555,000
Goodwill, balance at end of period	$ 1,977,670	$ 1,977,670

Lease Commitments (Details)

Lease Commitments (Details)	Jun. 30, 2015USD ($)
Operating Leased Assets [Line Items]
Year 2,015	$ 277,488
Year 2,016	443,258
Year 2,017	205,620
Operating Leases, Future Minimum Payments Due	926,366
Office Space
Operating Leased Assets [Line Items]
Year 2,015	261,936
Year 2,016	412,154
Year 2,017	186,516
Operating Leases, Future Minimum Payments Due	860,606
Computer/Office Equipment
Operating Leased Assets [Line Items]
Year 2,015	15,552
Year 2,016	31,104
Year 2,017	19,104
Operating Leases, Future Minimum Payments Due	$ 65,760

Lease Commitments (Details Narr

Lease Commitments (Details Narrative) - Jun. 30, 2015 - USD ($)	Total
CTS - Office Space
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 6,000
Leasing arrangements	CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $3,550 in utilities, realty taxes, and operating costs. The Lease renewed in April 2013 for a period of five years and will expire in March 2018.
Rental credit	$ 28,000
SMI - Off Site Server
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 1,092
Leasing arrangements	SMI has a lease for its off-site servers. The lease is accounted for as an operating lease on a month-to-month basis.
SMI - Office Space - Pottsville, Pennsylvania
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 7,111
Leasing arrangements	SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions.
SMI - Office Space - Dallas, Texas
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 1,540
Leasing arrangements	SMI has a lease for office space that will expire in August 31, 2015.
PIV
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 14,990
Leasing arrangements	PIV has a lease for office space in Venice, Florida. The lease will expire October 1, 2016.
PIN
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 9,543
Leasing arrangements	PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020.
PIC
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$ 5,512
Leasing arrangements	PIC has a lease for office space in Port Charlotte, Florida. The lease will expire June 20, 2016.

Accounts Payable and Accrued 45

Accounts Payable and Accrued Liabilities (Details Narrative) - USD ($)	Jun. 30, 2015		Dec. 31, 2014
Payables and Accruals [Abstract]
Trade payables and accrued expenses	$ 1,092,204		$ 935,688
Trade payables	$ 764,660	[1]	$ 624,141	[2]
[1]	Includes $165,733 was related to accrued payroll and withholdings liabilities, and $161,811 was related to Federal and State income tax owing.
[2]	Includes $73,461 was related to accrued payroll and withholdings liabilities, and $238,086 was related to Federal and State income tax owing.

Obligations Under Capital Lea46

Obligations Under Capital Lease (Details) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	$ 120,726
Minimum future lease payments, 2016	241,400
Minimum future lease payments, 2017	108,435
Minimum future lease payments, 2018	93,625
Minimum future lease payments, 2019	83,356
Minimum future lease payments, 2020	3,094
Total minimum lease payments	650,637
Less amount representing interest	63,202
Present value of minimum lease payments	587,435
Less current portion of minimum lease payments	208,519
Obligations Under Capital Lease, long term portion	378,916	$ 459,853
SMI - MRI
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	66,076
Minimum future lease payments, 2016	132,152
Minimum future lease payments, 2017	0
Minimum future lease payments, 2018	0
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	198,228
Less amount representing interest	15,580
Present value of minimum lease payments	182,648
Less current portion of minimum lease payments	118,551
Obligations Under Capital Lease, long term portion	64,096
SMI - PACS/RIS Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	18,690
Minimum future lease payments, 2016	37,380
Minimum future lease payments, 2017	37,380
Minimum future lease payments, 2018	37,380
Minimum future lease payments, 2019	34,265
Minimum future lease payments, 2020	0
Total minimum lease payments	165,095
Less amount representing interest	19,415
Present value of minimum lease payments	145,680
Less current portion of minimum lease payments	29,862
Obligations Under Capital Lease, long term portion	115,819
SMI - Xray Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	8,972
Minimum future lease payments, 2016	17,944
Minimum future lease payments, 2017	17,944
Minimum future lease payments, 2018	17,944
Minimum future lease payments, 2019	11,963
Minimum future lease payments, 2020	0
Total minimum lease payments	74,768
Less amount representing interest	9,186
Present value of minimum lease payments	65,582
Less current portion of minimum lease payments	14,206
Obligations Under Capital Lease, long term portion	51,376
PV, PN, PC PACS/RIS Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	18,590
Minimum future lease payments, 2016	37,128
Minimum future lease payments, 2017	37,128
Minimum future lease payments, 2018	37,128
Minimum future lease payments, 2019	37,128
Minimum future lease payments, 2020	3,094
Total minimum lease payments	170,196
Less amount representing interest	15,684
Present value of minimum lease payments	154,512
Less current portion of minimum lease payments	31,211
Obligations Under Capital Lease, long term portion	123,301
PV, PN, PC Computers Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	4,879
Minimum future lease payments, 2016	9,758
Minimum future lease payments, 2017	8,945
Minimum future lease payments, 2018	0
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	23,582
Less amount representing interest	2,767
Present value of minimum lease payments	20,814
Less current portion of minimum lease payments	7,992
Obligations Under Capital Lease, long term portion	12,822
CTS Computers Lease
Capital Leases Future Minimum Payments
Minimum future lease payments, 2015	3,519
Minimum future lease payments, 2016	7,038
Minimum future lease payments, 2017	7,038
Minimum future lease payments, 2018	1,173
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	18,768
Less amount representing interest	568
Present value of minimum lease payments	18,200
Less current portion of minimum lease payments	6,697
Obligations Under Capital Lease, long term portion	$ 11,502

Obligations Under Capital Lea47

Obligations Under Capital Lease (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
SMI - MRI
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$ 555,000		$ 555,000
Capital leases, equipment, net	268,333		268,333
Capital leases, depreciation expense	27,750	$ 27,750	55,500	$ 55,500
Capital leases, accumulated amortization	286,667		$ 286,667
Capital leases, leasing arrangements			On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
SMI - PACS/RIS Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	162,333		$ 162,333
Capital leases, equipment, net	140,688		140,688
Capital leases, depreciation expense	8,117	0	16,234	0
Capital leases, accumulated amortization	21,644		$ 21,644
Capital leases, leasing arrangements			On August 19, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $3,115, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the system for a total purchase price of $1.00.
SMI - Xray Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	78,250		$ 78,250
Capital leases, equipment, net	62,600		62,600
Capital leases, depreciation expense	3,913	0	7,827	0
Capital leases, accumulated amortization	15,650		$ 15,650
Capital leases, leasing arrangements			On July 03, 2014 Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.
PV, PN, PC PACS/RIS Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	167,107		$ 167,107
Capital leases, equipment, net	149,003		149,003
Capital leases, depreciation expense	8,355	0	16,710	0
Capital leases, accumulated amortization	18,103		$ 18,103
Capital leases, leasing arrangements			On November 26, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, PIV, is to make monthly payments of $3,094, plus applicable sales tax, over a period of 60 months. At the end of the lease, PIV will have the option to purchase the system for a total purchase price of $1.00.
PV, PN, PC Computers Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	25,108		$ 25,108
Capital leases, equipment, net	20,575		20,575
Capital leases, depreciation expense	2,092	0	4,184	0
Capital leases, accumulated amortization	4,533		$ 4,533
Capital leases, leasing arrangements			On December 10, 2014 Company has entered into a capital lease agreement to lease computers that were delivered and installed in December 2014. Under the terms of the lease, the Company is to make monthly payments of $813.16, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00.
CTS Computers Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	20,399		$ 20,399
Capital leases, equipment, net	17,566		17,566
Capital leases, depreciation expense	1,725	$ 0	2,875	$ 0
Capital leases, accumulated amortization	$ 2,833		$ 2,833
Capital leases, leasing arrangements			On January 21, 2015 the company has entered into a capital lease agreement to lease computers that were installed on the same date of acceptance. Under the terms of the lease, the company is to make monthly payments of $651.43, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00.

Convertible Notes - Details of

Convertible Notes - Details of Series B and C Notes (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Debt Instrument [Line Items]
Convertible note, amortization of debt discount	$ 177,607	$ 22,640	$ 289,898	$ 42,996
Convertible note, maturity date	Jul. 7, 2016		Aug. 18, 2015		Feb. 1, 2015
Series B - Note 1
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 25,000
Convertible note, accrued interest			1,500
Convertible note, payments			(1,500)
Convertible note, amortization of debt discount			188
Convertible note, unamortized debt discount			(344)
Convertible note, ending balance	$ 24,844		$ 24,844		$ 25,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 2
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 125,000
Convertible note, accrued interest			7,500
Convertible note, payments			(7,500)
Convertible note, amortization of debt discount			2,487
Convertible note, unamortized debt discount			(5,594)
Convertible note, ending balance	121,894		$ 121,894		125,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 3
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 50,000
Convertible note, accrued interest			3,000
Convertible note, payments			(3,000)
Convertible note, amortization of debt discount			563
Convertible note, unamortized debt discount			(1,031)
Convertible note, ending balance	49,531		$ 49,531		50,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 4
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 25,000
Convertible note, accrued interest			1,500
Convertible note, payments			(1,500)
Convertible note, amortization of debt discount			188
Convertible note, unamortized debt discount			(344)
Convertible note, ending balance	24,844		$ 24,844		25,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 5
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 25,000
Convertible note, accrued interest			1,500
Convertible note, payments			(1,500)
Convertible note, amortization of debt discount			188
Convertible note, unamortized debt discount			(344)
Convertible note, ending balance	24,844		$ 24,844		25,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 6
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 25,000
Convertible note, accrued interest			1,500
Convertible note, payments			(1,500)
Convertible note, amortization of debt discount			188
Convertible note, unamortized debt discount			(344)
Convertible note, ending balance	24,844		$ 24,844		25,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 7
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 1,500,000
Convertible note, accrued interest			90,000
Convertible note, payments			(90,000)
Convertible note, amortization of debt discount			33,750
Convertible note, unamortized debt discount			(61,875)
Convertible note, ending balance	1,471,875		$ 1,471,875		1,500,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 8
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 50,000
Convertible note, accrued interest			3,000
Convertible note, payments			(3,000)
Convertible note, amortization of debt discount			563
Convertible note, unamortized debt discount			(1,031)
Convertible note, ending balance	49,530		$ 49,530		50,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 9
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 15,000
Convertible note, accrued interest			900
Convertible note, payments			(900)
Convertible note, amortization of debt discount			113
Convertible note, unamortized debt discount			(206)
Convertible note, ending balance	14,906		$ 14,906		15,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 10
Debt Instrument [Line Items]
Convertible note, issuance date			Dec. 3, 2012
Convertible note, beginning balance			$ 100,000
Convertible note, accrued interest			6,000
Convertible note, payments			(6,000)
Convertible note, amortization of debt discount			1,711
Convertible note, unamortized debt discount			(3,656)
Convertible note, ending balance	98,056		$ 98,056		100,000
Convertible note, maturity date			Dec. 31, 2015
Series B - Note 11
Debt Instrument [Line Items]
Convertible note, issuance date			Mar. 27, 2013
Convertible note, beginning balance			$ 25,000
Convertible note, accrued interest			1,500
Convertible note, payments			(1,500)
Convertible note, amortization of debt discount			258
Convertible note, unamortized debt discount			(646)
Convertible note, ending balance	24,613		$ 24,613		25,000
Convertible note, maturity date			Mar. 31, 2016
Series B - Note 12
Debt Instrument [Line Items]
Convertible note, issuance date			Mar. 27, 2013
Convertible note, beginning balance			$ 25,000
Convertible note, accrued interest			1,500
Convertible note, payments			(1,500)
Convertible note, amortization of debt discount			258
Convertible note, unamortized debt discount			(646)
Convertible note, ending balance	24,613		$ 24,613		25,000
Convertible note, maturity date			Mar. 31, 2016
Series B - Note 13
Debt Instrument [Line Items]
Convertible note, issuance date			Mar. 27, 2013
Convertible note, beginning balance			$ 25,000
Convertible note, accrued interest			1,500
Convertible note, payments			(1,500)
Convertible note, amortization of debt discount			258
Convertible note, unamortized debt discount			(646)
Convertible note, ending balance	24,613		$ 24,613		25,000
Convertible note, maturity date			Mar. 31, 2016
Series C - Note 1
Debt Instrument [Line Items]
Convertible note, issuance date			May 22, 2014
Convertible note, beginning balance			$ 50,000
Convertible note, proceeds			0
Convertible note, accrued interest			3,000
Convertible note, payments			(3,000)
Convertible note, amortization of debt discount			500
Convertible note, unamortized debt discount			(2,417)
Convertible note, ending balance	48,083		$ 48,083		50,000
Convertible note, maturity date			May 31, 2017
Series C - Note 2
Debt Instrument [Line Items]
Convertible note, issuance date			May 22, 2014
Convertible note, beginning balance			$ 22,500
Convertible note, proceeds			0
Convertible note, accrued interest			1,350
Convertible note, payments			(1,350)
Convertible note, amortization of debt discount			225
Convertible note, unamortized debt discount			(1,088)
Convertible note, ending balance	21,638		$ 21,638		22,500
Convertible note, maturity date			May 31, 2017
Series C - Note 3
Debt Instrument [Line Items]
Convertible note, issuance date			May 22, 2014
Convertible note, beginning balance			$ 22,500
Convertible note, proceeds			0
Convertible note, accrued interest			1,350
Convertible note, payments			(1,350)
Convertible note, amortization of debt discount			225
Convertible note, unamortized debt discount			(1,088)
Convertible note, ending balance	21,638		$ 21,638		22,500
Convertible note, maturity date			May 31, 2017
Series C - Note 4
Debt Instrument [Line Items]
Convertible note, issuance date			Aug. 25, 2014
Convertible note, beginning balance			$ 50,000
Convertible note, proceeds			0
Convertible note, accrued interest			3,000
Convertible note, payments			(3,000)
Convertible note, amortization of debt discount			662
Convertible note, unamortized debt discount			(3,419)
Convertible note, ending balance	47,243		$ 47,243		50,000
Convertible note, maturity date			Oct. 31, 2017
Series C - Note 5
Debt Instrument [Line Items]
Convertible note, issuance date			Aug. 25, 2014
Convertible note, beginning balance			$ 25,000
Convertible note, proceeds			0
Convertible note, accrued interest			1,500
Convertible note, payments			(1,500)
Convertible note, amortization of debt discount			331
Convertible note, unamortized debt discount			(1,709)
Convertible note, ending balance	23,622		$ 23,622		25,000
Convertible note, maturity date			Oct. 31, 2017
Series C - Note 6
Debt Instrument [Line Items]
Convertible note, issuance date			Oct. 31, 2014
Convertible note, beginning balance			$ 50,000
Convertible note, proceeds			0
Convertible note, accrued interest			3,000
Convertible note, payments			(3,000)
Convertible note, amortization of debt discount			438
Convertible note, unamortized debt discount			(2,479)
Convertible note, ending balance	47,957		$ 47,957		50,000
Convertible note, maturity date			Oct. 31, 2017
Series C - Note 7
Debt Instrument [Line Items]
Convertible note, issuance date			Feb. 17, 2015
Convertible note, beginning balance			$ 0
Convertible note, proceeds			20,000
Convertible note, accrued interest			800
Convertible note, payments			(800)
Convertible note, amortization of debt discount			116
Convertible note, unamortized debt discount			(1,040)
Convertible note, ending balance	$ 19,076		$ 19,076		$ 0
Convertible note, maturity date			Feb. 17, 2018

Convertible Notes - Summary of

Convertible Notes - Summary of Individually Issued Notes (Details) - Convertible Notes - Individually Issued - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Convertible notes	$ 260,000	$ 300,000
Less: unamortized debt discount	(14,875)	(19,125)
Convertible notes principal, net	245,125	280,875
Less: Payment in period	(44,725)	(66,504)
Added: Accrued interest	14,725	26,504
Total convertible notes, net	215,125	240,875
Less: Short term portion, net	56,120	54,263
Long term portion, net	$ 159,005	$ 186,612

Convertible Notes - Long-Term D

Convertible Notes - Long-Term Debt Maturities (Details) - Jun. 30, 2015 - Convertible Notes - USD ($)	Total
Individually Issued
Debt Instrument [Line Items]
Principal payments, 2015	$ 30,000
Principal payments, 2016	60,000
Principal payments, 2017	140,000
Principal payments, 2018	0
Principal payments, 2019	0
Interest payments, 2015	20,339
Interest payments, 2016	20,748
Interest payments, 2017	2,625
Interest payments, 2018	0
Interest payments, 2019	0
Amortization expense, 2015	6,375
Amortization expense, 2016	8,500
Amortization expense, 2017	2,125
Amortization expense, 2018	0
Amortization expense, 2019	0
Series C Notes
Debt Instrument [Line Items]
Principal payments, 2015	0
Principal payments, 2016	0
Principal payments, 2017	220,000
Principal payments, 2018	20,000
Principal payments, 2019	0
Interest payments, 2015	14,400
Interest payments, 2016	24,400
Interest payments, 2017	12,650
Interest payments, 2018	400
Interest payments, 2019	0
Amortization expense, 2015	2,380
Amortization expense, 2016	4,876
Amortization expense, 2017	3,429
Amortization expense, 2018	58
Amortization expense, 2019	0
Series B Notes
Debt Instrument [Line Items]
Principal payments, 2015	1,865,000
Principal payments, 2016	150,000
Principal payments, 2017	0
Principal payments, 2018	0
Principal payments, 2019	0
Interest payments, 2015	120,900
Interest payments, 2016	4,500
Interest payments, 2017	0
Interest payments, 2018	0
Interest payments, 2019	0
Amortization expense, 2015	34,443
Amortization expense, 2016	1,550
Amortization expense, 2017	0
Amortization expense, 2018	0
Amortization expense, 2019	$ 0

Convertible Notes (Details Narr

Convertible Notes (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Convertible notes, payment terms	The loan terms call for a daily payment of $1,066, towards the principal balance and interest.		The loan terms call for weekly payments of $28,000 towards the principal balance and interest.
Convertible notes, interest rate					12.00%
Amortization of debt discount	$ 177,607	$ 22,640	$ 289,898	$ 42,996
Convertible Notes | Individually Issued
Debt Instrument [Line Items]
Convertible notes, sold					$ 300,000
Convertible notes, payment terms					The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. The Company will also be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for 3 years until the note due date of February 27, 2017.
Convertible notes, price per share for conversion of shares of common stock					$ 0.15
Convertible notes, interest rate					12.00%
Note holder additions					The non-affiliate will receive 300,000 shares as part of the note agreement.
Additional paid in capital and discount			25,500
Amortization of debt discount			4,250
Convertible note, accrued interest			14,725
Private placement, maturity date					Feb. 27, 2017
Common stock issued					300,000
Convertible Notes | Series C Notes
Debt Instrument [Line Items]
Convertible notes, sold			20,000		$ 125,000
Convertible notes, payment terms					Series C Notes bear interest at a rate of 12% per annum, payable to the holder at 1% per month, with principal amount due May 31, 2017.
Convertible notes, price per share for conversion of shares of common stock					$ 0.15
Convertible notes, interest rate					12.00%
Additional paid in capital and discount			12,695
Amortization of debt discount			2,496
Convertible note, accrued interest			$ 14,000
Private placement, 12% convertible notes, principal amount					$ 95,000
Private placement, maturity date					May 31, 2017
Common stock issued	240,000		240,000
Convertible Notes | Series B Notes
Debt Instrument [Line Items]
Convertible notes, sold						$ 150,000
Convertible notes, payment terms						Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month.
Convertible notes, price per share for conversion of shares of common stock						$ 0.10
Convertible notes, interest rate						12.00%
Additional paid in capital and discount			$ 244,275
Amortization of debt discount			40,713
Convertible note, accrued interest			$ 120,900
Private placement, 12% convertible notes, principal amount						$ 1,865,000
Private placement, maturity date, description						Series B Notes issued December 3, 2012 for $1,865,000 mature on December 31, 2015 and Series B Notes issued March 27, 2013 for $150,000 mature on March 31, 2016.
Common stock issued						5,315,000

Promissory Notes (Details)

Promissory Notes (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Promissory notes, beginning of period	$ 134,999	$ 45,015
Proceeds from notes issuances	1,008,063	50,000
Promissory note assigned		64,937
Accrued interest	496	6,069
Payments through end of period	(662,787)	(31,022)
Amortization of debt discount	(99,502)
Promissory notes, end of period	381,269	$ 134,999
Promissory notes, short-term portion	381,269
Promissory notes, long-term portion	$ 0

Promissory Notes (Details Narra

Promissory Notes (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2015	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Promissory note, payments through end of period		$ 54,000
Promissory note, additional proceeds		$ 4,000	$ 50,000
Promissory note, assigned			$ 64,937
Promissory note, interest rate			12.00%
Promissory note, maturity date	Jul. 7, 2016	Aug. 18, 2015	Feb. 1, 2015
Short term loan payable issued	$ 284,062	$ 720,000
Short term loan payable, repayment terms	The loan terms call for a daily payment of $1,066, towards the principal balance and interest.	The loan terms call for weekly payments of $28,000 towards the principal balance and interest.

Royalty Financing (Details Narr

Royalty Financing (Details Narrative) - Jun. 30, 2015 - USD ($)	Total
Royalty Financing
Royalty payments	$ 241,203
Discounted amortization expense	228,826
Accrued royalties	$ 1,987,623

Major Customers (Details)

Major Customers (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Revenue, Major Customer [Line Items]
Major customer percent of revenue	13.00%		16.00%
Customer/Contract A
Revenue, Major Customer [Line Items]
Major customer revenues	$ 0	$ 529,754
Major customer percent of revenue	0.00%	21.00%
Customer/Contract E
Revenue, Major Customer [Line Items]
Major customer revenues	$ 436,666	$ 455,253
Major customer percent of revenue	12.00%	18.00%
Customer/Contract F
Revenue, Major Customer [Line Items]
Major customer revenues	$ 262,019	$ 279,189
Major customer percent of revenue	7.00%	11.00%
Customer/Contract H
Revenue, Major Customer [Line Items]
Major customer revenues	$ 157,695	$ 149,408
Major customer percent of revenue	4.00%	6.00%

Major Vendors (Details Narrativ

Major Vendors (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Major Vendors
Expenses for system software and support	$ 14,040	$ 12,569

Common Stock Transactions (Deta

Common Stock Transactions (Details Narrative) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Convertible Notes | Individually Issued
Shares issued, convertible notes, shares		300,000
Shares issued, convertible notes, value		$ 25,500
Convertible Notes | Series C Notes
Shares issued, convertible notes, shares	20,000	220,000
Shares issued, convertible notes, value	$ 1,040	$ 14,280
Common Stock
Shares issued for services, shares	200,000	5,000
Shares issued for services, value	$ 10,340	$ 150
Consulting
Stock options, granted	4,200,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 34,683
Chief Executive Officer
Stock options, granted	4,200,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 34,683
Chief Financial Officer
Stock options, granted	1,600,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 13,213

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Going Concern
Total Comprehensive Income (Loss)	$ 23,864	$ (10,336)	$ (342,710)	$ (49,546)
Working capital deficit	$ 2,434,102		$ 2,434,102

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	1 Months Ended
	Jul. 31, 2015USD ($)
Subsequent Event | Loans Payable
Subsequent Event [Line Items]
Loan payable	$ 260,000